The company's proprietary technology platform isolates beneficial microbes based on their functional traits, allowing for the development of next-generation health products. BioMillenia focuses on creating topical and ingestible non-GMO smart strains that address microbial imbalance for skin, women & infant, immune, and digestive health. Founded in 2014 and based in Romainville, France, BioMillenia aims to restore a robust and resilient microbiota by isolating previously uncultured microbes.